当前位置:首页 - 行情中心 - 艾迪药业(688488) - 财务分析 - 现金流量表

艾迪药业

(688488)

  

流通市值:50.49亿  总市值:50.49亿
流通股本:4.21亿   总股本:4.21亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金561,333,182.61361,414,067.4184,943,492.27697,381,262.66
  收到的税费返还2,170,431.312,170,431.31--
  收到其他与经营活动有关的现金85,721,119.7257,037,192.0224,806,383.24166,817,841.86
  经营活动现金流入小计649,224,733.64420,621,690.73209,749,875.51864,199,104.52
  购买商品、接受劳务支付的现金109,654,899.2981,250,610.3149,322,261.59137,909,145.87
  支付给职工以及为职工支付的现金126,521,468.7188,650,132.3550,243,699.61142,434,709.29
  支付的各项税费68,660,821.2251,758,926.1629,778,225.23100,187,234.2
  支付其他与经营活动有关的现金266,723,432.15173,901,871.0779,511,844.26466,036,514.39
  经营活动现金流出小计571,560,621.37395,561,539.89208,856,030.69846,567,603.75
  经营活动产生的现金流量净额77,664,112.2725,060,150.84893,844.8217,631,500.77
二、投资活动产生的现金流量:
  取得投资收益收到的现金973,470.29509,980.44382,220.951,510,922.15
  处置固定资产、无形资产和其他长期资产收回的现金净额35,000--4,084,860.43
  收到的其他与投资活动有关的现金310,000,000110,000,00080,000,000391,000,000
  投资活动现金流入小计311,008,470.29110,509,980.4480,382,220.95396,595,782.58
  购建固定资产、无形资产和其他长期资产支付的现金38,041,524.526,727,661.677,834,953.9847,934,622.84
  投资支付的现金---5,250,000
  取得子公司及其他营业单位支付的现金5,040,0005,040,000-5,040,000
  支付其他与投资活动有关的现金335,020,000120,000,00030,000,000365,000,000
  投资活动现金流出小计378,101,524.5151,767,661.6737,834,953.98423,224,622.84
  投资活动产生的现金流量净额-67,093,054.21-41,257,681.2342,547,266.97-26,628,840.26
三、筹资活动产生的现金流量:
  取得借款收到的现金533,824,000496,924,000328,380,000477,924,000
  筹资活动现金流入小计533,824,000496,924,000328,380,000477,924,000
  偿还债务支付的现金398,710,000311,528,000172,228,000404,656,000
  分配股利、利润或偿付利息支付的现金18,116,111.5313,381,129.884,079,228.1320,871,234.53
  支付其他与筹资活动有关的现金132,813,727132,048,099.7270,452,665.142,358,778.6
  筹资活动现金流出小计549,639,838.53456,957,229.6246,759,893.27427,886,013.13
  筹资活动产生的现金流量净额-15,815,838.5339,966,770.481,620,106.7350,037,986.87
四、汇率变动对现金及现金等价物的影响-220,511.77-164,972.9-71,035.3-101,064.52
五、现金及现金等价物净增加额-5,465,292.2423,604,267.11124,990,183.2240,939,582.86
  加:期初现金及现金等价物余额365,199,115.63365,199,115.63365,199,115.63324,259,532.77
  期末现金及现金等价物余额359,733,823.39388,803,382.74490,189,298.85365,199,115.63
补充资料:
  净利润-32,170,963.33-8,083,067.42
  资产减值准备-140,834.7-17,011,257.89
  固定资产和投资性房地产折旧-16,406,099.39-33,489,540.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-16,406,099.39-33,489,540.73
  无形资产摊销-10,785,093.48-19,307,775.33
  长期待摊费用摊销-3,019,422.06-5,163,806.31
  处置固定资产、无形资产和其他长期资产的损失--1,350,583.61--81,281.88
  固定资产报废损失-26,143.71-169,273.7
  公允价值变动损失-3,820,158.49--18,221,056.17
  财务费用-8,570,351.83-15,620,774.14
  投资损失-356,371.06-736,346.86
  递延所得税-1,739,859.23-1,697,912.4
  其中:递延所得税资产减少-2,188,921.99-128,601.58
    递延所得税负债增加--449,062.76-1,569,310.82
  存货的减少--12,756,337.43--21,531,059.96
  经营性应收项目的减少--20,458,869.19--24,117,918.85
  经营性应付项目的增加--23,938,291.98--26,220,010.77
  其他-4,360,929.59-3,706,401.78
  现金的期末余额-388,803,382.74-365,199,115.63
  减:现金的期初余额-365,199,115.63-324,259,532.77
  现金及现金等价物的净增加额-23,604,267.11-40,939,582.86
公告日期2026-10-302026-08-292026-04-302026-03-31
审计意见(境内)标准无保留意见
TOP↑